RecruitingNot ApplicableNCT04278118

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

HiPPI: A Phase 2 Trial of Hypofractionated Pencil Beam Scanning Proton Therapy for Benign Intracranial Tumors


Sponsor

Emory University

Enrollment

70 participants

Start Date

Feb 18, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This phase II trial studies how well hypofractionated proton or photon radiation therapy works in treating patients with brain tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells. A shorter duration of radiation treatment may avoid some of the delayed side effects of radiation while providing a more convenient treatment and reducing costs.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study, called HiPPI, tests whether a shorter but higher-dose course of proton radiation therapy (called hypofractionation) works just as well as standard longer courses for treating benign (non-cancerous) brain tumors. Proton therapy is a precise form of radiation that reduces damage to surrounding healthy brain tissue. **You may be eligible if...** - You have been diagnosed with a benign brain or nerve sheath tumor — such as a meningioma, pituitary adenoma, or schwannoma — confirmed by imaging or biopsy - Your doctor recommends fractionated radiation therapy (proton or standard) - You have signed the consent form **You may NOT be eligible if...** - You are pregnant or may become pregnant - There are specific medical reasons you cannot safely receive radiation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONHypofractionated Radiation Therapy

Undergo hypofractionated proton or photon radiation therapy

RADIATIONPhoton Beam Radiation Therapy

Undergo hypofractionated proton or photon radiation therapy

RADIATIONProton Beam Radiation Therapy

Undergo hypofractionated proton or photon radiation therapy

OTHERQuality-of-Life Assessment

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04278118


Related Trials